[Sinovac Reports Unaudited Third Quarter Financial Results -- Conference call scheduled for Thursday, November 12, 2015 at 8:00 AM ET -- BEIJING, November 11, 2015 /PRNewswire/ -- Sinovac Biotech Ltd. (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced today its unaudited third quarter and nine month financial results for the period ended September 30, 2015. Third Quarter] []
[Xinyuan Real Estate Co., Ltd. Announces Third Quarter 2015 Financial Results 3Q15 Contract Sales Up 84.7% YoY to US$309.7 Million 3Q15 Total GFA Sales Up 132.6% YoY to 233,300 Square Meters 3Q15 Net Income Up 609.4% YoY to US$22.7 Million BEIJING, China, November 13, 2015 Third Quarter 2015 Highlights · Total third quarter revenue increased by 88.9% to US$309.0 million] []
[Sinovac Reports Unaudited Third Quarter Financial Results -- Conference call scheduled for Thursday, November 12, 2015 at 8:00 AM ET -- BEIJING, November 11, 2015 /PRNewswire/ -- Sinovac Biotech Ltd. (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced today its unaudited third quarter and nine month financial results for the period ended September 30, 2015. Third Quarter] []
[29 October 2015 Golden Meditech Holdings Limited 48 th 1 Garden Road Central Hong Kong Dear Sirs, Purchase Agreement dated 8 May 2015 relating to the Sale Shares and Note (the Purchase Agreement) We refer to the Purchase Agreement. Defined terms used in the Purchase Agreement are also used in this Letter Agreement. In accordance with Clause 3.1 of the] []
[29 October 2015 Golden Meditech Holdings Limited 48 th 1 Garden Road Central Hong Kong Dear Sirs, Purchase Agreement dated 8 May 2015 relating to the Sale Shares and Note (the Purchase Agreement) We refer to the Purchase Agreement. Defined terms used in the Purchase Agreement are also used in this Letter Agreement. In accordance with Clause 3.1 of the] []
[] [I, Edward Yihua Kang, certify that: 1. I have reviewed this quarterly report on Form 10-Q for the period ending September 30, 2015 of Ever-Glory International Group, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light] [I, Jiansong Wang, certify that: 1. I have reviewed this quarterly report on Form 10-Q for the period ending September 30, 2015 of Ever-Glory International Group, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of] [Section 906 of Sarbanes-Oxley Act of 2002 1. 2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Edward Yihua Kang EX-32.1 4 f10q0915ex32i_everglory.htm CERTIFICATION] [Section 906 of Sarbanes-Oxley Act of 2002 1. 2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Jiansong Wang (Principal Financial Officer) EX-32.2 5 f10q0915ex32ii_everglory.htm CERTIFICATION]
